Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient with Non-Hodgkin Lymphoma on FDG PET/CT

Nir Hod, Sophie Lantsberg, Reut Anconina, Daniel Levin, Karen Nalbandyan, Itai Levi

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

A 64-year-old man was treated with multiagent chemotherapy owing to high-grade non-Hodgkin lymphoma presenting as a bulky disease involving the spleen. Interim and posttreatment sequential FDG PET/CT scans revealed a residual splenic mass showing markedly intense FDG uptake suspected of a residual viable lymphoma. To definitely decide about the appropriate treatment, a laparoscopic splenectomy was performed. Histopathologic specimen was compatible with the rare diagnosis of postchemotherapy histiocyte-rich pseudotumor of the spleen, a potential pitfall simulating viable disease on FDG PET/CT.

Original languageEnglish
Pages (from-to)E409-E412
JournalClinical Nuclear Medicine
Volume44
Issue number6
DOIs
StatePublished - 1 Jun 2019

Keywords

  • FDG PET/CT
  • follicular lymphoma
  • non-Hodgkin lymphoma
  • pitfall
  • postchemotherapy histiocyte-rich pseudotumor
  • spleen

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient with Non-Hodgkin Lymphoma on FDG PET/CT'. Together they form a unique fingerprint.

Cite this